Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SRC as a potential therapeutic target in solid tumor oncology

Gary E Gallick1

  • 1University of Texas M. D. Anderson Cancer Center, TX, USA.

Clinical Advances in Hematology & Oncology : H&O
|September 16, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of Concern for JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.

The Journal of clinical investigation·2025
Same author

Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Editor's Note: Functional Roles of <i>Src</i> and <i>Fgr</i> in Ovarian Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4.

iScience·2021
Same author

Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture <i>In Vitro</i> and Reduces Bone Osteolysis <i>In Vivo</i>.

Molecular cancer therapeutics·2020